Imprimis Pharmaceuticals Inc IMMY:NASDAQ (Common Stock)
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
|---|---|---|---|---|
| 7.49 | -0.23 -2.98% | 7,514 | 16.5K |
Latest News Headlines for Imprimis Pharmaceuticals Inc
Latest Annual and Quarterly SEC Filings
More FilingsCompany Background
Imprimis Pharmaceuticals Inc. is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company's Transdel cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier. Ketotransdel, the Company's lead pain product, utilizes the Transdel platform technology to deliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), through the skin directly into the underlying tissues where the drug exerts its anti-inflammatory and analgesic effects. Ketotransdel consists of a transdermal formulation of ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), and its Transdel drug delivery system and is being developed for the treatment of acute pain. In April 2014, Imprimis Pharmaceuticals Inc acquired Pharmacy Creations LLC, a Randolph-based owner and operator of pharmacies.
collapse, right-facing arrow indicating collapsed view of sectionOverview
| Bid | Size | -- | -- |
|---|---|
| Ask | Size | -- | -- |
| Price Open | 7.73 |
| Previous Close | 7.49 |
| Day High | -- |
| Day Low | -- |
| 52 Week High | 3/3/2014 | 9.62 |
| 52 Week Low | 12/13/2013 | 3.01 |
| % Off 52 Week High | -22.14% |
| % Off 52 Week Low | 148.84% |
| Beta (5 Yr) | -1.30 |
| Volatility Avg | 10/8/2014 | 61.65 |
| 10-Day Avg. Volume | 16,503 |
| Market data is delayed by at least 20 minutes. | |
collapse, right-facing arrow indicating collapsed view of sectionFundamentals
| EPS (TTM) | 6/30/2014 | -0.98 |
|---|---|
| P/E Ratio | 6/30/2014 | -- |
| Market Cap | Micro Cap | 68M |
| Shares Outstanding | 9.13M |
| Float | 4.7M |
collapse, right-facing arrow indicating collapsed view of sectionDividends
| Dividend Yield | -- |
|---|---|
| Ex-Date | -- |
| Dividend Announcement | -- |
| Date of Record | -- |
| Payable | -- - -- |
| Payable Date | -- |
Peers Information HelpIMMY Imprimis Pharmaceuticals Inc vs. Peers
| Peers | |
|---|---|
IMMY Imprimis Pharmaceuticals Inc | 122.92% |
Eli Lilly and Co | 27.92% |
Merck & Co., Inc. | 20.24% |
IMMY Imprimis Pharmaceuticals Inc | 0.00% |
Eli Lilly and Co | 3.00% |
Merck & Co., Inc. | 2.92% |
IMMY Imprimis Pharmaceuticals Inc | -2.98% |
Eli Lilly and Co | 1.59% |
Merck & Co., Inc. | 2.94% |